These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1745512)

  • 1. Effects of pilocarpine on salivary flow in patients with Sjögren's syndrome.
    Rhodus NL; Schuh MJ
    Oral Surg Oral Med Oral Pathol; 1991 Nov; 72(5):545-9. PubMed ID: 1745512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome.
    Rhodus NL
    Oral Dis; 1997 Jun; 3(2):93-8. PubMed ID: 9467349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. s-IgA and cytokine levels in whole saliva of Sjögren's syndrome patients before and after oral pilocarpine hydrochloride administration: a pilot study.
    Rhodus N; Dahmer L; Lindemann K; Rudney J; Mathur A; Bereuter J
    Clin Oral Investig; 1998 Dec; 2(4):191-6. PubMed ID: 10388393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögren's syndrome. Correlation with clinical, immunological and histological features.
    Rosas J; Ramos-Casals M; Ena J; García-Carrasco M; Verdu J; Cervera R; Font J; Caballero O; Ingelmo M; Pascual E
    Rheumatology (Oxford); 2002 Jun; 41(6):670-5. PubMed ID: 12048294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of long-term pilocarpine due to increased muscarinic acetylcholine receptor 3 in salivary glands.
    Minagi HO; Ikai K; Araie T; Sakai M; Sakai T
    Biochem Biophys Res Commun; 2018 Sep; 503(2):1098-1102. PubMed ID: 29953856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pilocarpine on salivary flow in patients with Sjogren's syndrome.
    Fox PC; Mandel ID
    Oral Surg Oral Med Oral Pathol; 1992 Sep; 74(3):315-8. PubMed ID: 1407993
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome.
    Jorkjend L; Bergenholtz A; Johansson AK; Johansson A
    Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjögren's syndrome.
    Tomiita M; Takei S; Kuwada N; Nonaka Y; Saito K; Shimojo N; Kohno Y
    Mod Rheumatol; 2010 Oct; 20(5):486-90. PubMed ID: 20517630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.
    Nusair S; Rubinow A
    Semin Arthritis Rheum; 1999 Jun; 28(6):360-7. PubMed ID: 10406404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy prediction of cevimeline in patients with Sjögren's syndrome.
    Yamada H; Nakagawa Y; Wakamatsu E; Sumida T; Yamachika S; Nomura Y; Mishima K; Saito I
    Clin Rheumatol; 2007 Aug; 26(8):1320-7. PubMed ID: 17221146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren's syndrome.
    Izumi M; Eguchi K; Nakamura H; Takagi Y; Kawabe Y; Nakamura T
    Ann Rheum Dis; 1998 Aug; 57(8):464-9. PubMed ID: 9797551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
    Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
    Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis on pharmacological therapies in the management of xerostomia in patients with Sjogren's syndrome.
    Garlapati K; Kammari A; Badam RK; B E S; Boringi M; Soni P
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):312-318. PubMed ID: 30932714
    [No Abstract]   [Full Text] [Related]  

  • 15. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group.
    Vivino FB; Al-Hashimi I; Khan Z; LeVeque FG; Salisbury PL; Tran-Johnson TK; Muscoplat CC; Trivedi M; Goldlust B; Gallagher SC
    Arch Intern Med; 1999 Jan; 159(2):174-81. PubMed ID: 9927101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 0.1% pilocarpine mouthwash on xerostomia: double-blind, randomised controlled trial.
    Kim JH; Ahn HJ; Choi JH; Jung DW; Kwon JS
    J Oral Rehabil; 2014 Mar; 41(3):226-35. PubMed ID: 24527846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans levels in patients with Sjögren's syndrome before and after long-term use of pilocarpine hydrochloride: a pilot study.
    Rhodus NL; Liljemark W; Bloomquist C; Bereuter J
    Quintessence Int; 1998 Nov; 29(11):705-10. PubMed ID: 10200720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjögren's syndrome in Taiwan--a double-blind, placebo-controlled trial.
    Wu CH; Hsieh SC; Lee KL; Li KJ; Lu MC; Yu CL
    J Formos Med Assoc; 2006 Oct; 105(10):796-803. PubMed ID: 17000452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with Sjögren's syndrome.
    Takagi Y; Sumi M; Nakamura H; Sato S; Kawakami A; Nakamura T
    Rheumatology (Oxford); 2016 Feb; 55(2):237-45. PubMed ID: 26338664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of xerostomic medications on stimulated salivary flow rate in patients with Sjögren's syndrome.
    Simmons DD; Al-Hashimi I; Haghighat N
    Quintessence Int; 2000 Mar; 31(3):196-200. PubMed ID: 11203926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.